These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 21168610)
1. Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation. Uchida J; Machida Y; Iwai T; Naganuma T; Kitamoto K; Iguchi T; Maeda S; Kamada Y; Kuwabara N; Kim T; Nakatani T Transplant Proc; 2010 Dec; 42(10):3998-4002. PubMed ID: 21168610 [TBL] [Abstract][Full Text] [Related]
2. A novel approach to successful ABO-incompatible high-titer renal transplantation. Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213 [TBL] [Abstract][Full Text] [Related]
3. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803 [TBL] [Abstract][Full Text] [Related]
4. ABO-incompatible kidney transplantation in elderly patients over 60 years of age. Uchida J; Iwai T; Machida Y; Kuwabara N; Kabei K; Murao M; Otoshi T; Naganuma T; Kumada N; Nakatani T Int Urol Nephrol; 2012 Oct; 44(5):1563-70. PubMed ID: 22828739 [TBL] [Abstract][Full Text] [Related]
5. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients. Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587 [TBL] [Abstract][Full Text] [Related]
6. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M; Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951 [TBL] [Abstract][Full Text] [Related]
7. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports. Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272 [TBL] [Abstract][Full Text] [Related]
8. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report. Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation. Sugiyama K; Hyodo Y; Aikawa A Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258 [TBL] [Abstract][Full Text] [Related]
10. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588 [TBL] [Abstract][Full Text] [Related]
11. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810 [TBL] [Abstract][Full Text] [Related]
12. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Sawada T; Fuchinoue S; Teraoka S Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255 [TBL] [Abstract][Full Text] [Related]
13. Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients. Tojimbara T; Yashima J; Shirai H; Yamazaki T; Koyama I; Nakajima I Transplant Proc; 2020; 52(6):1705-1708. PubMed ID: 32444132 [TBL] [Abstract][Full Text] [Related]